• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

需要透析的肾病患者中韦格纳肉芽肿病的长期预后。

Longterm outcome of Wegener's granulomatosis in patients with renal disease requiring dialysis.

作者信息

Mekhail T M, Hoffman G S

机构信息

Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Ohio, USA.

出版信息

J Rheumatol. 2000 May;27(5):1237-40.

PMID:10813293
Abstract

OBJECTIVE

It is known that renal failure is a poor prognostic marker for survival in Wegener's granulomatosis (WG). We investigated the longterm outcome of patients with WG who have severe renal disease requiring dialysis.

METHODS

We performed a retrospective analysis of 104 patients with WG followed at our institution between 1982 and 1997. Twenty-three patients who required dialysis were studied in detail to determine outcomes and factors that influenced survival and restoration of renal function.

RESULTS

Of 23 dialysis dependent patients with WG, 11 died (Group 1). 7 either remained dialysis dependent or received successful renal transplants (Group 2), and 5 substantially recovered renal function (Group 3). Mean serum creatinine at the end of a mean followup period of 38.4 months for Group 3 was 1.8 mg/dl. There was no apparent difference between groups in regard to disease profile, e.g., distribution of organ involvement or serum creatinine when renal impairment was first recognized (mean serum creatinine for groups: 1: 3.0 mg/dl; 2: 5.6 mg/dl; 3: 5.5 mg/dl) and peak serum creatinine prior to dialysis (means for groups: 1: 9.5 mg/dl; 2: 10.5 mg/dl; 3: 9.6 mg/dl). Infection secondary to immunosuppression was the leading cause of death in Group I patients.

CONCLUSION

Because the clinical profile and degree of renal failure, as judged by serum creatinine, did not differ among patients who did or did not regain dialysis independent renal function, we recommend aggressive immunosuppressive therapy in all cases of active WG with acute rapidly worsening renal failure, regardless of the severity of renal impairment.

摘要

目的

已知肾衰竭是韦格纳肉芽肿(WG)患者生存的不良预后指标。我们调查了患有严重肾脏疾病需要透析的WG患者的长期预后。

方法

我们对1982年至1997年间在我院随访的104例WG患者进行了回顾性分析。对23例需要透析的患者进行了详细研究,以确定其预后以及影响生存和肾功能恢复的因素。

结果

23例依赖透析的WG患者中,11例死亡(第1组)。7例要么继续依赖透析,要么接受了成功的肾移植(第2组),5例肾功能基本恢复(第3组)。第3组在平均38.4个月的随访期末,平均血清肌酐为1.8mg/dl。在疾病特征方面,如器官受累分布或首次发现肾功能损害时的血清肌酐水平(各组平均血清肌酐:第1组:3.0mg/dl;第2组:5.6mg/dl;第3组:5.5mg/dl)以及透析前血清肌酐峰值(各组平均值:第1组:9.5mg/dl;第2组:10.5mg/dl;第3组:9.6mg/dl),各组之间无明显差异。免疫抑制继发感染是第1组患者的主要死亡原因。

结论

由于根据血清肌酐判断,恢复或未恢复非透析依赖肾功能的患者的临床特征和肾衰竭程度无差异,因此我们建议,对于所有急性快速进展性肾衰竭的活动性WG患者,无论肾功能损害的严重程度如何,均应积极进行免疫抑制治疗。

相似文献

1
Longterm outcome of Wegener's granulomatosis in patients with renal disease requiring dialysis.需要透析的肾病患者中韦格纳肉芽肿病的长期预后。
J Rheumatol. 2000 May;27(5):1237-40.
2
Crescentic glomerulonephritis in Wegener's granulomatosis: morphology, therapy, outcome.韦格纳肉芽肿病中的新月体性肾小球肾炎:形态学、治疗及预后
Clin Nephrol. 1991 Jun;35(6):243-51.
3
Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome.伴肾脏受累的韦格纳肉芽肿病:患者生存率及初始肾功能、肾脏组织学、治疗与肾脏转归之间的相关性
Clin Nephrol. 1991 Apr;35(4):139-47.
4
Survival of patients with Wegener's granulomatosis diagnosed in Finland in 1981-2000.1981-2000 年芬兰诊断的 Wegener 肉芽肿患者的生存情况。
Scand J Rheumatol. 2010;39(1):71-6. doi: 10.3109/03009740903140701.
5
Wegener's granulomatosis in Finland in 1981-2000: risk of dialysis-dependent renal disease.芬兰 1981-2000 年韦格纳肉芽肿:透析依赖型肾病的风险。
Scand J Rheumatol. 2011;40(4):283-8. doi: 10.3109/03009742.2010.533693. Epub 2011 Jan 13.
6
Improved outcome in Wegener's granulomatosis and microscopic polyangiitis? A retrospective analysis of 95 cases in two cohorts.韦格纳肉芽肿病和显微镜下多血管炎的预后改善?两个队列中95例病例的回顾性分析。
J Intern Med. 2009 Apr;265(4):496-506. doi: 10.1111/j.1365-2796.2008.02060.x. Epub 2008 Dec 23.
7
Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis. Long-term renal outcome in patients with glomerulonephritis.
Arthritis Rheum. 2000 Aug;43(8):1836-40. doi: 10.1002/1529-0131(200008)43:8<1836::AID-ANR20>3.0.CO;2-R.
8
Classical versus non-renal Wegener's granulomatosis.经典型与非肾型韦格纳肉芽肿病
Q J Med. 1994 Mar;87(3):161-7.
9
Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients.系统性韦格纳肉芽肿病死亡率的预测:基于93例患者的生存分析
Arthritis Rheum. 2004 Feb 15;51(1):83-91. doi: 10.1002/art.20082.
10
Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).韦格纳肉芽肿病所致损害及其治疗:来自韦格纳肉芽肿病依那西普试验(WGET)的前瞻性数据。
Arthritis Rheum. 2005 Jul;52(7):2168-78. doi: 10.1002/art.21117.

引用本文的文献

1
Granulomatosis with Polyangiitis: A Focus on Differences and Similarities Between Child and Adult Patients.肉芽肿性多血管炎:儿童与成人患者的差异与相似之处聚焦
Medicina (Kaunas). 2025 Mar 18;61(3):534. doi: 10.3390/medicina61030534.
2
ANCA-Associated Vasculitis: An Update.抗中性粒细胞胞浆抗体相关血管炎:最新进展
J Clin Med. 2021 Apr 1;10(7):1446. doi: 10.3390/jcm10071446.
3
Costs of Disease Relapses Among Individuals with Granulomatosis, with Polyangiitis, or Microscopic Polyangiitis in the United States.美国肉芽肿伴多血管炎或显微镜下多血管炎患者疾病复发的成本
Rheumatol Ther. 2018 Jun;5(1):159-170. doi: 10.1007/s40744-018-0099-1. Epub 2018 Feb 22.
4
[S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].[S1指南:抗中性粒细胞胞浆抗体相关血管炎的诊断与治疗]
Z Rheumatol. 2017 Nov;76(Suppl 3):77-104. doi: 10.1007/s00393-017-0394-1.
5
Rituximab for treatment of severe renal disease in ANCA associated vasculitis.利妥昔单抗用于治疗抗中性粒细胞胞浆抗体相关性血管炎的严重肾脏疾病。
J Nephrol. 2016 Apr;29(2):195-201. doi: 10.1007/s40620-015-0208-y. Epub 2015 May 19.
6
Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans.非裔美国人寡免疫性肾小球肾炎的临床特征及预后
Semin Arthritis Rheum. 2014 Jun;43(6):778-83. doi: 10.1016/j.semarthrit.2013.11.011. Epub 2013 Dec 4.
7
Management of acute renal failure in the elderly patient: a clinician's guide.老年患者急性肾衰竭的管理:临床医生指南。
Drugs Aging. 2008;25(6):455-76. doi: 10.2165/00002512-200825060-00002.
8
Wegener's granulomatosis: clinical and laboratory results of a university hospital study of 20 patients from Turkey.
Clin Rheumatol. 2006 May;25(3):358-63. doi: 10.1007/s10067-005-0057-5. Epub 2005 Dec 15.
9
Wegener's granulomatosis presenting as a pleural effusion.以胸腔积液为表现的韦格纳肉芽肿病。
BMJ. 2003 Jul 12;327(7406):95-6. doi: 10.1136/bmj.327.7406.95.